Resources from the same session
411MO - Petosemtamab (MCLA-158) monotherapy in previously treated (2L+) recurrent/metastatic (r/m) head and neck squamous cell carcinoma (HNSCC): Phase II trial
Presenter: Christophe Le Tourneau
Session: Mini Oral session: Head and neck cancers
Resources:
Abstract
Slides
Webcast
412MO - A real-world phase IV superiority study among recurrent or advanced head and neck cancer patients prescribed with low-dose nivolumab and triple metronomic chemotherapy versus paclitaxel carboplatin regimen
Presenter: Avinash Khadela
Session: Mini Oral session: Head and neck cancers
Resources:
Abstract
413MO - Impacts of time-of-day of nivolumab infusion on treatment efficacy for patients with head and neck squamous cell carcinoma
Presenter: Takuro Tsunoki
Session: Mini Oral session: Head and neck cancers
Resources:
Abstract
Slides
Webcast